MB&B Seminar: "PARP Inhibitors: Mechanisms of Action and Cancer Treatment Paradigms"

Eli Rothenberg, of NYU School of Medicine, specializes in development of new cutting-edge single-molecule fluorescence imaging techniques, computational methods and novel assays and their applications for studying molecular mechanisms relevant to diverse human diseases and syndromes, for biomarker discovery and therapeutic targets and for pharmacological mechanisms-of-action.